Modelling time-varying covariates effect on survival via functional data analysis: application to the MRC BO06 trial in osteosarcoma

被引:7
作者
Spreafico, Marta [1 ,2 ,3 ]
Ieva, Francesca [1 ,3 ,4 ]
Fiocco, Marta [2 ,5 ,6 ]
机构
[1] Politecn Milan, Dept Math, MOX Lab Modeling & Sci Comp, I-20133 Milan, Italy
[2] Leiden Univ, Math Inst, Leiden, Netherlands
[3] Univ Milano Bicocca, CHRP Natl Ctr Healthcare Res & Pharmacoepidemiol, I-20126 Milan, Italy
[4] CHDS Ctr Hlth Data Sci, Human Technopole, I-20157 Milan, Italy
[5] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands
[6] Princess Maxima Ctr Pediat Oncol, Trial & Data Ctr, Utrecht, Netherlands
关键词
Functional data analysis; Time-varying covariates; Survival analysis; Osteosarcoma; CLASSIFICATION; CHEMOTHERAPY;
D O I
10.1007/s10260-022-00647-0
中图分类号
O21 [概率论与数理统计]; C8 [统计学];
学科分类号
020208 ; 070103 ; 0714 ;
摘要
Time-varying covariates are of great interest in clinical research since they represent dynamic patterns which reflect disease progression. In cancer studies biomarkers values change as functions of time and chemotherapy treatment is modified by delaying a course or reducing the dose intensity, according to patient's toxicity levels. In this work, a Functional covariate Cox Model (FunCM) to study the association between time-varying processes and a time-to-event outcome is proposed. FunCM first exploits functional data analysis techniques to represent time-varying processes in terms of functional data. Then, information related to the evolution of the functions over time is incorporated into functional regression models for survival data through functional principal component analysis. FunCM is compared to a standard time-varying covariate Cox model, commonly used despite its limiting assumptions that covariate values are constant in time and measured without errors. Data from MRC BO06/EORTC 80931 randomised controlled trial for treatment of osteosarcoma are analysed. Time-varying covariates related to alkaline phosphatase levels, white blood cell counts and chemotherapy dose during treatment are investigated. The proposed method allows to detect differences between patients with different biomarkers and treatment evolutions, and to include this information in the survival model. These aspects are seldom addressed in the literature and could provide new insights into the clinical research.
引用
收藏
页码:271 / 298
页数:28
相关论文
共 50 条
[31]   A k-means procedure based on a Mahalanobis type distance for clustering multivariate functional data [J].
Martino, Andrea ;
Ghiglietti, Andrea ;
Ieva, Francesca ;
Paganoni, Anna Maria .
STATISTICAL METHODS AND APPLICATIONS, 2019, 28 (02) :301-322
[32]   Functional modelling and classification of longitudinal data [J].
Müller, HG .
SCANDINAVIAN JOURNAL OF STATISTICS, 2005, 32 (02) :223-240
[33]   Overall C as a measure of discrimination in survival analysis:: model specific population value and confidence interval estimation [J].
Pencina, MJ ;
D'Agostino, RB .
STATISTICS IN MEDICINE, 2004, 23 (13) :2109-2123
[34]   Joint modeling of repeated multivariate cognitive measures and competing risks of dementia and death: a latent process and latent class approach [J].
Proust-Lima, Cecile ;
Dartigues, Jean-Francois ;
Jacqmin-Gadda, Helene .
STATISTICS IN MEDICINE, 2016, 35 (03) :382-398
[35]   OPTIMAL ESTIMATION FOR THE FUNCTIONAL COX MODEL [J].
Qu, Simeng ;
Wang, Jane-Ling ;
Wang, Xiao .
ANNALS OF STATISTICS, 2016, 44 (04) :1708-1738
[36]  
R Core Team, 2020, R LANG ENV STAT COMP
[37]  
Ramsay J. O., 2002, APPL FUNCTIONAL DATA, DOI DOI 10.1007/B98886
[38]  
Ramsay J. O., 2005, FUNCTIONAL DATA ANAL
[39]   Prognostic Significance of Serum Alkaline Phosphatase Level in Osteosarcoma: A Meta-Analysis of Published Data [J].
Ren, Hai-Yong ;
Sun, Ling-Ling ;
Li, Heng-Yuan ;
Ye, Zhao-Ming .
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[40]   Osteosarcoma [J].
Ritter, J. ;
Bielack, S. S. .
ANNALS OF ONCOLOGY, 2010, 21 :320-325